The Relationship Between Serum Calcitonin and Calcium in the Hemodialysis Patient

https://doi.org/10.1016/S0272-6386(12)80749-9Get rights and content

An increase in the serum calcium level is known to stimulate calcitonin secretion, but whether calcitonin contributes to calcium regulation in the dialysis patient is not known. Because we recently observed in the rat that (1) a sigmoidal calcitonin-calcium curve was present, and (2) calcitonin stimulation decreased the calcemic response to parathyroid hormone (PTH), the relationship between serum calcitonin and calcium was studied in six hemodialysis patients. To evaluate both the calcitonin-calcium and PTH-calcium relationships, hemodialysis with a low-calcium dialysate (2 mg/dL) was performed and followed 1 week later by hemodialysis with a high-calcium dialysate (8 mg/dL). The calcitonin-calcium relationship was best represented as a sigmoidal curve that was opposite in direction to the PTH-calcium curve. The range of the calcitonin-calcium curve was less than the PTH-calcium curve; as a percent of maximal, the minimal calcitonin was higher than the minimal PTH, 61% ± 5% versus 26% ± 4% (P < 0.001). As opposed to the PTH-calcium curve in which the basal PTH value was intermediate between the minimal and maximal PTH, the basal calcitonin value was close to the minimal calcitonin. Despite a wide range of ionized serum calcium concentrations (3.5 to 5.3 mg/dL), maximal stimulation was greater than maximal inhibition of calcitonin, 60% ± 13% versus 3% ± 2% (P = 0.01). Finally, a significant correlation was observed between basal and maximal calcitonin (r = 0.99, P < 0.001). In summary, (1) a sigmoidal calcitonin-calcium curve opposite in direction to the PTH-calcium curve was observed; (2) the range of the calcitonin-calcium curve was less than the PTH-calcium curve; (3) the serum calcium level at which calcitonin was stimulated appeared to be dependent on the basal serum calcium; and (4) the correlation between basal and maximal calcitonin levels suggests that the mass of calcitonin-secreting cells may vary among hemodialysis patients.

References (29)

  • JG Parthemore et al.

    Calcitonin secretion in normal human subjects

    J Clin Endocrinol Metab

    (1978)
  • LA Austin et al.

    Regulation of calcitonin secretion in normal man by changes of serum calcium within the physiologic range

    J Clin Invest

    (1979)
  • DE Carey et al.

    Calcitonin secretion in congenital nongoitrous cretinism

    J Clin Invest

    (1980)
  • K Emmertrenk et al.

    Altered vitamin D metabolism and bone remodelling in patients with medullary thyroid carcinoma and hypercalcitonemia

    Metab Bone Dis Rel Res

    (1981)
  • Cited by (14)

    • Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease

      2021, Nefrologia
      Citation Excerpt :

      It remains to be clarified whether elevated sclerostin levels are the cause or consequence of the hyporesponsiveness to PTH in CKD.114 From the molecular point of view, it should also be mentioned the potential role of calcitonin (produced by the C cells of the thyroid gland) in the pathogenesis of SHPT and the reduced response to PTH in CKD.115–120 It is also relevant the role of elevated levels of osteoprotegerin, which could favor skeletal resistance to PTH through suppression of the genesis of osteoclasts.121

    • Blood Gases and Critical Care Testing: Physiology, Clinical Interpretations, and Laboratory Applications

      2021, Blood Gases and Critical Care Testing: Physiology, Clinical Interpretations, and Laboratory Applications
    View all citing articles on Scopus

    Presented in part at the 24th Annual Meeting of the American Society of Nephrology, Baltimore, MD, November 17–20, 1991.

    Dr Rodriguez's current address is Hospital Reina Sofia, Cordoba, Spain.

    This is a US government work. There are no restrictions on its use.

    View full text